Myxredlin recalls
Myxredlin products have been recalled 1 time, most recently on 9 Sep 2026. The recalling company is usually Baxter Healthcare. The most common reason is manufacturing (cgmp) deviations.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 9 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why myxredlin is recalled
Companies
Product types
By year
Ongoing myxredlin recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Myxredlin, Insulin Human in 0.9% Sodium Chloride Injection/mL) recalledMyxredlin | Baxter Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
All myxredlin recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Myxredlin, Insulin Human in 0.9% Sodium Chloride Injection/mL) recalledMyxredlin | Baxter Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.